Prostate carcinoma;Prostatakarzinom

Radiologe

Volumn 48, Issue 1, 2008, Pages 45-51

  Schlemmer, H P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Early detection; Epidemiology; Imaging; Prostate carcinoma; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSTATE BIOPSY; PROSTATE CARCINOMA; REVIEW; TRANSRECTAL ULTRASONOGRAPHY;

BIOPSY; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; DIGITAL RECTAL EXAMINATION; EARLY DIAGNOSIS; ENDOSONOGRAPHY; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SCREENING; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 38649096647     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-007-1555-z     Document Type: Review

References (36)

1. Grönberg H (2003) Prostate cancer epidemiology. Lancet 361: 859-864
2. Sakr WA, Haas GP, Cassin BF et al. (1993) The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 150: 379-385
3. Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12: 20-37
4. Heidenreich A (2007) Tumordiagnostik.,state of the art": Screening, Diagnostik und Staging des Prostatakarzinoms. Im Fokus Onkol 3: 54-61
5. Kirby RS, Christmas TJ, Brawer MK (2001) Screening of prostate cancer. In: Kirby RS, Christmas TJ, Brawer MK (eds) Prostata cancer, 2nd edn. Mosby, London Edinburgh New York, pp 77-90
6. Berger AP, Deibl M, Strasak A et al. (2006) Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: results from a screening population. Urology 68: 1067-1071
7. Pelzer AE, Tewari A, Bektic J et al. (2005) Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/ml: observation and clinical implications from Tyrol screening project. Urology 66: 1029-1033
8. Schlemmer HP (2006) Onkologische Früherkennung mittels Ganzkörper-MRT: Möglichkeiten, Herausforderungen und Grenzen. In: Goyen M (Hrsg) Echte Ganzkörper-MRT. ABW Wissenschaftsverlag, Berlin, S 121-142
9. Ellis WJ, Chetner MP, Preston SD, Brawer MK (1994) Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Urol 152: 1520-1525
10. Pelzer AE, Volgger H, Bektic J et al. (2005) The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels. BJU Int 96: 995-998
11. Frauscher F, Klauser A, Bergr AP et al. (2003) Sonographie des Prostatakarzinoms. Radiologe 43: 455-463
12. Schlemmer HP, Corvin S (2004) Methods for volume assessment of prostate cancer. Eur Radiol 14: 597-606
13. Harris R, Lohr KN (2002) Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137: 917-929
14. Oberaigner W, Horninger W, Klocker H et al. (2006) Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing. Am J Epidemiol 164: 376-384
15. Ross KS, Guess HA, Carter HB (2005) Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages. Urology 66: 1038-1042
16. Rifkin MD (1998) Prostate cancer: the diagnostic dilemma and the place of imaging and staging. World J Urol 16: 76-80
17. Carter HB, Hamper UM, Sheth S et al. (1989) Evaluation of transrectal ultrasound in the early detection of prostate cancer. J Urol 142: 1008-1010
18. Ellis WJ, Brawer MK (1994) The significance of isoechoic prostatic carcinoma. J Urol 152: 2304-2307
19. Egevad L, Frimmel H, Norberg M et al. (1999) Three-dimensional computer reconstruction of prostate cancer from radical prostatectomy specimens: evaluation of the model by core biopsy simulation. Urology 53: 192-198
20. Pallwein L, Mitterberger M, Gradl J et al. (2007) Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer. Curr Opin Urol 17: 39-47
21. Pelzer A, Bektic J, Berger AP et al. (2005) Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 173: 1926-1929
22. Heuck A, Scheidler J, Sommer B et al. (2003) MR-Tomographie des Prostatakarzinoms. Radiologe 43: 464-473
23. Graser A, Heuck A, Sommer B et al. (2007) Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology. AJR Am J Roentgenol 188: 84-90
24. Futterer JJ, Heijmink SW, Scheenen TW et al. (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241: 449-458
25. Reinsberg SA, Payne GS, Riches AF et al. (2007) Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 188: 91-98
26. Horn JJ, Coakley FV, Simko JP et al. (2007) High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features - initial experience. Radiology 242: 483-489
27. Futterer JJ, Scheenen TW, Huisman HJ et al. (2004) Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate. Invest Radiol 39: 671-680
28. Fütterer JJ, Heijmink SWTPJ, Scheenen TWJ et al. (2006) Prostate cancer: local staging at 3-T endorectal MR imaging - early experience. Radiology 238: 184-191
29. Beyersdorff D, Winkel A, Hamm B et al. (2005) MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 234: 576-581
30. Anastasiadis AG, Lichy MP, Nagele U et al. (2006) MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50: 738-748
31. Engelhard K, Hollenbach HP, Kiefer B et al. (2006) Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device. Eur Radiol 16: 1237-1243
32. Wang L, Hricak H, Kattan MW et al. (2006) Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. AJR Am J Roentgenol 186: 743-748
33. Harisinghani MG, Barentsz J, Hahn PF et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348: 2491-2499
34. Reske SN, Blumstein NM, Neumaier B et al. (2006) Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med 47: 1249-1254
35. Scher B, Seitz M, Albinger W et al. (2007) Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging 34: 45-53
36. Morris MJ, Scher HI (2007) 11C-acetate PET imaging in prostate cancer. Eur J Nucl Med Mol Imaging 34: 181-184